Devon Graham, PhD - Publications

Affiliations: 
Pharmacology Vanderbilt University School of Medicine, Nashville, TN, United States 

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Lee GS, Graham DL, Noble BL, Trammell TS, McCarthy DM, Anderson LR, Rubinstein M, Bhide PG, Stanwood GD. Behavioral and Neuroanatomical Consequences of Cell-Type Specific Loss of Dopamine D2 Receptors in the Mouse Cerebral Cortex. Frontiers in Behavioral Neuroscience. 15: 815713. PMID 35095443 DOI: 10.3389/fnbeh.2021.815713  0.601
2021 Graham DL, Madkour HS, Noble BL, Schatschneider C, Stanwood GD. Long-term functional alterations following prenatal GLP-1R activation. Neurotoxicology and Teratology. 87: 106984. PMID 33864929 DOI: 10.1016/j.ntt.2021.106984  0.578
2020 Trammell TS, Henderson NL, Madkour HS, Stanwood GD, Graham DL. GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 33222103 DOI: 10.1007/s10072-020-04910-8  0.541
2020 Graham DL, Durai HH, Trammell T, Noble BL, Mortlock DP, Galli A, Stanwood GD. A novel mouse model of glucagon-like peptide-1 receptor expression: a look at the brain. The Journal of Comparative Neurology. PMID 32170734 DOI: 10.1002/Cne.24905  0.594
2019 Goldfarb SS, Stanwood GD, Flynn HA, Graham DL. Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications. Experimental Biology and Medicine (Maywood, N.J.). 1535370219883601. PMID 31630569 DOI: 10.1177/1535370219883601  0.533
2016 Martin MM, Graham DL, McCarthy DM, Bhide PG, Stanwood GD. Cocaine-induced neurodevelopmental deficits and underlying mechanisms. Birth Defects Research. Part C, Embryo Today : Reviews. 108: 147-73. PMID 27345015 DOI: 10.1002/bdrc.21132  0.596
2016 Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, et al. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Translational Psychiatry. 6: e809. PMID 27187231 DOI: 10.1038/Tp.2016.86  0.644
2015 Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiology & Behavior. 149: 262-8. PMID 26072178 DOI: 10.1016/J.Physbeh.2015.06.013  0.642
2015 Graham DL, Buendia MA, Chapman MA, Durai HH, Stanwood GD. Deletion of Gαq in the telencephalon alters specific neurobehavioral outcomes. Synapse (New York, N.Y.). PMID 25963901 DOI: 10.1002/syn.21830  0.566
2015 Frederick AL, Yano H, Trifilieff P, Vishwasrao HD, Biezonski D, Mészáros J, Urizar E, Sibley DR, Kellendonk C, Sonntag KC, Graham DL, Colbran RJ, Stanwood GD, Javitch JA. Evidence against dopamine D1/D2 receptor heteromers. Molecular Psychiatry. PMID 25560761 DOI: 10.1038/Mp.2014.166  0.714
2015 Graham DL, Durai HH, Garden JD, Cohen EL, Echevarria FD, Stanwood GD. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex. Acs Chemical Neuroscience. 6: 297-305. PMID 25393953 DOI: 10.1021/cn500235m  0.646
2015 Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 61-87. PMID 24938210 DOI: 10.1038/npp.2014.147  0.572
2015 Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice Physiology and Behavior. 149: 262-268. DOI: 10.1016/j.physbeh.2015.06.013  0.605
2015 Ross E, Graham D, Stanwood G. Developmental dopamine D2 receptor effects on interneuron development and behavior Neurotoxicology and Teratology. 49: 131. DOI: 10.1016/J.Ntt.2015.04.100  0.65
2015 Graham D, Durai H, Garden J, Cohen E, Echevarria F, Stanwood G. NTX25Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex Neurotoxicology and Teratology. 49: 108. DOI: 10.1016/J.Ntt.2015.04.031  0.63
2013 Graham DL, Erreger K, Galli A, Stanwood GD. GLP-1 analog attenuates cocaine reward. Molecular Psychiatry. 18: 961-2. PMID 23089631 DOI: 10.1038/Mp.2012.141  0.623
2011 Graham D, Amos-Kroohs R, Braun A, Grace C, Schaefer T, Skelton M, Williams M, Vorhees C. Long-Term Receptor Alterations from Developmental Methamphetamine Exposure in Rats by Use of Selective Pharmacological Agonists and Antagonists Neurotoxicology and Teratology. 33: 497-498. DOI: 10.1016/J.Ntt.2011.05.024  0.342
2008 Graham DL, Noailles PA, Cadet JL. Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges. Journal of Neurochemistry. 105: 1873-85. PMID 18248616 DOI: 10.1016/J.Ntt.2008.03.052  0.318
Show low-probability matches.